Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB vs RITONAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSIMERTINIB vs RITONAVIR: Safety Overview

Metric OSIMERTINIB RITONAVIR
Total FAERS Reports 27,750 11,980
Deaths Reported 12,456 1,190
Death Rate 44.9% 9.9%
Hospitalizations 5,277 2,925
Average Patient Age 68.2 yrs 43.8 yrs
% Female Patients 66.0% 43.8%
FDA Approval Date Nov 13, 2015 Dec 3, 2020
Manufacturer AstraZeneca Pharmaceuticals LP AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued